Unified Patent Court (UPC) analytics are now available. Check here

Get Patent Opposition Report for Esteve Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore Esteve Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2817000Aug 4, 2021Oral Pharmaceutical Compositions Of Dabigatran Etexilate3